Millennium Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-113,300
| Closed | -$419K | – | 3989 |
|
|
2017
Q4 | $419K | Buy |
113,300
+51,000
| +82% | +$189K | ﹤0.01% | 2952 |
|
|
2017
Q3 | $255K | Buy |
+62,300
| New | +$255K | ﹤0.01% | 2868 |
|
|
2017
Q2 | – | Sell |
-342,351
| Closed | -$1.42M | – | 3756 |
|
|
2017
Q1 | $1.42M | Buy |
342,351
+295,215
| +626% | +$1.22M | ﹤0.01% | 2002 |
|
|
2016
Q4 | $203K | Sell |
47,136
-26,293
| -36% | -$113K | ﹤0.01% | 2863 |
|
|
2016
Q3 | $723K | Sell |
73,429
-32,808
| -31% | -$323K | ﹤0.01% | 2220 |
|
|
2016
Q2 | $601K | Buy |
+106,237
| New | +$601K | ﹤0.01% | 2181 |
|
|
2016
Q1 | – | Sell |
-21,951
| Closed | -$292K | – | 3540 |
|
|
2015
Q4 | $292K | Sell |
21,951
-4,466
| -17% | -$59.4K | ﹤0.01% | 2708 |
|
|
2015
Q3 | $434K | Sell |
26,417
-35,180
| -57% | -$578K | ﹤0.01% | 2527 |
|
|
2015
Q2 | $1.38M | Sell |
61,597
-90,483
| -59% | -$2.03M | ﹤0.01% | 1936 |
|
|
2015
Q1 | $1.49M | Buy |
152,080
+22,913
| +18% | +$224K | ﹤0.01% | 1956 |
|
|
2014
Q4 | $1.47M | Buy |
129,167
+12,500
| +11% | +$143K | ﹤0.01% | 1952 |
|
|
2014
Q3 | $1.34M | Buy |
116,667
+77,223
| +196% | +$890K | ﹤0.01% | 1834 |
|
|
2014
Q2 | $767K | Sell |
39,444
-9,961
| -20% | -$194K | ﹤0.01% | 2006 |
|
|
2014
Q1 | $886K | Sell |
49,405
-17,262
| -26% | -$310K | ﹤0.01% | 1879 |
|
|
2013
Q4 | $704K | Hold |
66,667
| – | – | ﹤0.01% | 1998 |
|
|
2013
Q3 | $824K | Sell |
66,667
-285,032
| -81% | -$3.52M | ﹤0.01% | 1771 |
|
|
2013
Q2 | $3.31M | Buy |
+351,699
| New | +$3.31M | 0.01% | 1055 |
|